We’re developing novel, endovascular devices that are safe.simple.effective.

See how
arrow

We’re well-positioned to make a splash in the endovascular space.

Our proven management team has deep domain expertise in the interventional space with robust catheter and generator development experience. We have strong relationships with global manufacturing partners and access to over 3,000 cardiovascular centers in all major geographies.

Our people
arrow

Our team is lean, but loaded with experience.

Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
JC Sun, PhD, MBA
Co-Founder and Advisor
Brady Hatcher
Co-Founder and Advisor
Our experience
arrow

Over the past two decades, we’ve led projects for a wonderful list of large and small medtech companies.

See the buzz
arrow
We’re just getting started, but people are already talking.
FastWave Medical Closes Series Pre-A Financing and Milestone-Based Acquisition Agreement
FastWave Medical Inc., a company incubated by partners of Big Sky Biomedical, announced today the closing of its Series Pre-A financing, led by a strategic partner from Asia. FastWave Medical is focused on providing endovascular solutions for arterial disease. The company’s website is fastwavemedical.com.
Read more
arrow
FastWave Medical, a Company Incubated by Partners of Big Sky Biomedical, Closes Series Pre-A Financing and Milestone-based Acquisition
Minority investment will be used to accelerate development and global expansion of the company’s novel endovascular therapies for arterial disease, and includes acquisition obligations upon the completion of key technical, clinical, and regulatory milestones.
Read more
arrow
FastWave Medical, a Company Incubated by Partners of Big Sky Biomedical, Closes Series Pre-A Financing and Milestone-based Acquisition
FastWave Medical Inc., a company incubated by partners of Big Sky Biomedical, announced today the closing of its Series Pre-A financing, led by a strategic partner from Asia. The minority investment will be used to advance research & development and achieve key regulatory initiatives for the company’s novel endovascular therapies for the treatment of calcific artery disease.
Read more
arrow
FastWave Medical closes Series Pre-A funding round, acquired by China Grand Pharmaceutical
FastWave Medical this week announced that it has closed its Series Pre-A financing round following its recent acquisition by China Grand Pharmaceutical and Healthcare Holdings.

Read more
arrow
Reach out if you’d like to chat.
© FastWave Medical Inc.
Back to top
arrow